![Lisa Carson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lisa Carson
Director of Finance/CFO at
PHIO PHARMACEUTICALS CORP.
Net worth: 206 132 $ as of 31/08/2026
Profile
Ms. Lisa Carson is a Chief Financial Officer at Phio Pharmaceuticals Corp.
Ms. Carson was previously employed as a Vice President-Finance & Controller by Prelude Therapeutics, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 28/09/2026 | 189,112 ( 1.63% ) | 206 132 $ | 31/08/2026 |
Lisa Carson active positions
| Companies | Position | Start |
|---|---|---|
| PHIO PHARMACEUTICALS CORP. | Director of Finance/CFO | 12/05/2025 |
Former positions of Lisa Carson
| Companies | Position | End |
|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Comptroller/Controller/Auditor | 01/11/2024 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
25
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Phio Pharmaceuticals Corp.
 Phio Pharmaceuticals Corp. BiotechnologyHealth Technology Develops RNAi-based medical technologies and therapies | Health Technology |
Prelude Therapeutics, Inc.
 Prelude Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines targeting chromatin function to treat cancer and rare diseases | Health Technology |
- Stock Market
- Insiders
- Lisa Carson
